ACCEPTABILITY OF OPPORTUNISTIC SCREENING FOR OCCULT GASTROINTESTINAL BLOOD-LOSS

被引:38
作者
HOBBS, FDR
CHERRY, RC
FIELDING, JWL
PIKE, L
HOLDER, R
机构
[1] UNIV BIRMINGHAM,STAT,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[2] GREENBANK MED CTR,BIRMINGHAM B28 8BG,ENGLAND
[3] QUEEN ELIZABETH HOSP,BIRMINGHAM B15 2TJ,ENGLAND
[4] BIRMINGHAM FAMILY HLTH SERV AUTHOR,BIRMINGHAM B6 5RQ,ENGLAND
关键词
D O I
10.1136/bmj.304.6825.483
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - To test patient compliance for faecal occult blood testing in suburban and inner city general practice. Design - Prospective opportunistic trial using the Haemoccult test kit. Tests were offered during routine surgery attendance. Setting - Three group general practices in Birmingham. Subjects - All patients aged 40 years or older on the start date who routinely attended surgery during two years. Main outcome measures - Numbers of patients approached for testing and the numbers refusing, accepting, and returning the test kits. Results - Only 26.3% (1230/4677) of the potential target population had been screened within the two years, although 988 (39.3%) of the suburban practice target were screened. However, 55.7% (1230/2207) of patients actually offered a test returned completed kits, with only 6% (133) refusing the kit. 683 (61.6%) patients aged 50-69 returned kits, compared with 343 (54.3%) aged 70 or over and 204 (43.8%) aged 40-49. These differences were significant (p < 0.001). Patients from the inner city practice were significantly less likely to be offered the test than those in suburban practice (242 (11.2%) v 988 (39.9%), p < 0.001) and return the samples (242 (38.8%) v 988 (62.4%), p < 0.001). Patients from the inner city practice were also more likely to refuse the test (78 (12.5%) v 55 (3.5%), p < 0.001). Conclusions - Opportunistic testing for occult faecal blood in asymptomatic patients was reasonably acceptable to patients, especially those in a suburban practice. If the test is shown to reduce mortality from colorectal cancer then formal screening would probably achieve acceptable target rates, especially among patients aged 50-69, who represent the prime risk group.
引用
收藏
页码:483 / 486
页数:4
相关论文
共 24 条
[21]  
STOATE HG, 1989, J ROY COLL GEN PRACT, V39, P193
[22]  
WEATHERALL DJ, 1983, OXFORD TXB MED, V1
[23]  
WILSON JMG, 1968, WHO34 PUBL HLTH PAP
[24]  
1989, COMPENDIUM HLTH STAT